AXONIS Therapeutics
Biotechnology
Overview
AXONIS Therapeutics, Inc. is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders.
Funding and backers
Total raised
$46M
7 rounds on record
Latest round
$46M
Venture round · Oct 2024 · 2 yr ago
Grants
$3.8M
6 grants · CORDIS
Backers
2
Lumira Ventures, venBio Partners
The money's age
Due for its next round
24 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 1, 2024
Won a grant $323k · CORDIS
Jun 15, 2023
Won a grant $300k · CORDIS
Sep 24, 2022
Won a grant $336k · CORDIS
Sep 1, 2022
Won a grant $299k · CORDIS
Mar 1, 2022
Won a grant $2.2M · CORDIS
Sep 30, 2020
Won a grant $331k · CORDIS
Funding rounds
Registers and programsofficial lists and records that name the company
| Legal entity | Axonis Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Donald Manning M.D. Ph.DExecutive OfficerSEC Form D
Jeffrey ImbaroExecutive OfficerSEC Form D
Shane HegartyExecutive OfficerSEC Form D
Joanna StanickaExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
IgniteScientific Progress. Precision-engineered infrastructure for breakthrough discoveries.
Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience…
Psilera is a biotechnology company developing groundbreaking first-in-class treatments for neurological disorders by creating a new class…
Degrading proteins.Saving lives.. Biotheryx is advancing a portfolio of first-in-class protein degraders, with an initial focus on…
KisoJi Biotechnology. Breakthrough antibody discovery forbreakthrough therapeutics.
Parrots harnesses the power of AI & ML to provide real-time voice & telecare solutions to people with advanced neurological disorders.
Visa sponsorship
0
H-1B filings in 12 months
0
Open roles in United States
In the register as Axonis Therapeutics, Inc., Boston, MA
Other sponsors in the same field
Daiichi Sankyo 
Curia 
Dechert 
Kashiv Biosciences
Alert me
US Department of Labor · latest filing Jun 3, 2025 · Visa details by country
Financials
Total raised
$49.8M
Latest round
Venture - Series Unknown
Funding rounds
7
People
Donald Manning M.D. Ph.D
Executive Officer
Jeffrey Imbaro
Executive Officer
Shane Hegarty
Executive Officer
Joanna Stanicka
Executive Officer, Director
Corey Goodman
Director
Brock Reeve
Director
Jonathan Leff
Director
Raymond Kelleher
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
venBio PartnersVia a fund
Lumira VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston
United States
HQ
Axonis Therapeutics, Inc.
75 Kneeland Street, 14th Fl., Boston, MA 02111